Montes, Christopher Axcel P.

HRN: 22-01-47  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/30/2022
AMPICILLIN 1GM (VIAL)
11/30/2022
12/07/2022
IV
130mg
Q6
Pneumonia
Waiting Final Action 
01/19/2023
AMPICILLIN 500MG (VIAL)
01/19/2023
01/27/2023
IV
320 Mg
Q6
PCAP C
Waiting Final Action 
11/14/2023
CEFUROXIME 750MG (VIAL)
11/14/2023
11/21/2023
IV
250 Mg
Q8
Pcap B, AGE With Severe Dehydration
Checking Final Appropriateness 
11/16/2023
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
11/16/2023
11/18/2023
PO
5mL
BID
Ascariasis
Checking Final Appropriateness 
11/17/2023
CEFTRIAXONE 1G (VIAL)
11/17/2023
11/23/2023
IVT
370mg
Q12
AGE With Severe Dehydration
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: